drugset / Trial / NCT00777062
VIVITROL as a Treatment for Cocaine and Alcohol Dependence
Phase 2
Completed
80 enrolled
University of Pennsylvania
Alkermes, Inc. · collabNational Institute on Drug Abuse (NIDA) · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
To evaluate the efficacy of VIVITROL (naltrexone for extended-release injectable suspension) for the treatment of co-occurring cocaine and alcohol dependence
Timeline
- Start
- 2009-07
- Primary completion
- 2012-07
- Completion
- 2013-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Naltrexone | Small molecule | 380 mg | — |